New hope for relapsed leukemia: experimental drug CTX-712 enters human trials
Disease control
Recruiting now
This study tests an experimental drug called CTX-712 in adults with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that have not responded to or returned after prior treatments. The goal is to find the safest dose and see if the drug can shrink or control the can…
Phase: PHASE1, PHASE2 • Sponsor: Chordia Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC